New drug cocktail shows promise in battling blood cancer before and after transplant
NCT ID NCT01816971
First seen Apr 25, 2026 · Last updated Apr 30, 2026 · Updated 2 times
Summary
This study tested a combination of three drugs (carfilzomib, lenalidomide, and dexamethasone) given before and after a stem cell transplant in 76 people newly diagnosed with multiple myeloma. The goal was to see how well this approach could control the cancer. While the treatment aims to reduce or eliminate cancer cells, multiple myeloma typically requires ongoing management, so this is considered a disease control strategy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE I MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber
Boston, Massachusetts, 02215, United States
-
Princess Margaret
Toronto, Ontario, M5T 2M9, Canada
-
Sarah Cannon Cancer Center
Nashville, Tennessee, 37203, United States
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637-1470, United States
-
Washington University in St Louis
St Louis, Missouri, 63130, United States
Conditions
Explore the condition pages connected to this study.